Massachusetts Financial Services
IMUX icon

Massachusetts Financial Services’s Immunic IMUX Stock Holding History

Massachusetts Financial Services’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,197
Closed -$183K – 937
2020
Q4 		$183K Sell
1,197
-12
-1% -$2.15K ﹤0.01% 877
2020
Q3 		$225K Buy
+1,209
New +$198K ﹤0.01% 859

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services's IMUX Position: Q1 2021 in Review

Massachusetts Financial Services sold out of Immunic (IMUX) in Q1 2021, closing a stake of 1,197 shares — an estimated $183K sold.

Massachusetts Financial Services first reported a position in IMUX in Q3 2020 and held it in 2 quarters. The position peaked at $225K in Q3 2020. 63 funds tracked by Wall St. Rank hold IMUX as of Q1 2021.

  • Massachusetts Financial Services reported no remaining Immunic position as of Q1 2021 after selling out during the quarter.
  • Massachusetts Financial Services sold 1,197 Immunic shares in Q1 2021, an estimated $183K.
  • Massachusetts Financial Services first reported a position in Immunic in Q3 2020 and held it in 2 quarters.
  • Massachusetts Financial Services's Immunic position peaked at $225K in Q3 2020.
  • 63 funds tracked by Wall St. Rank held Immunic as of Q1 2021.

Based on Massachusetts Financial Services's 13F filing for Q1 2021, filed 13 May 2021.